{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:41:51Z","timestamp":1790800911923,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0147947","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T17:37:50Z","timestamp":1459532270000},"page":"e0147947","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":88,"title":["Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson\u2019s Disease Stages?"],"prefix":"10.1371","volume":"11","author":[{"given":"Lucie","family":"Hopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Grolez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Ryckewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Carri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Laloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Petrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Devedjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Defebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Jissendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Delmaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2174\/092986711795496863","article-title":"Oxidation chemistry of catecholamines and neuronal degeneration: an update","volume":"18","author":"A Napolitano","year":"2011","journal-title":"Curr Med Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"DT Dexter","year":"1987","journal-title":"Lancet"},{"key":"ref3","first-page":"61","article-title":"Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease","volume":"4","author":"PD Griffiths","year":"1993","journal-title":"Dementia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jmri.21563","article-title":"MRI assessment of basal ganglia iron deposition in Parkinson's disease","volume":"28","author":"LI Wallis","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/brain\/awq212","article-title":"Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature","volume":"133","author":"P P\u00e9ran","year":"2010","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.parkreldis.2013.08.011","article-title":"Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease","volume":"19","author":"N Bunzeck","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/mds.23643","article-title":"Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease","volume":"26","author":"G Du","year":"2011","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","article-title":"Midbrain iron content in early Parkinson disease: A potential biomarker of disease status","volume":"70","author":"WRW Martin","year":"2008","journal-title":"Neurology"},{"key":"ref9","article-title":"Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up","author":"M Ulla","year":"2013","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"D Devos","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10072-013-1595-2","article-title":"Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease","volume":"35","author":"D Aquino","year":"2014","journal-title":"Neurol Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1227\/01.NEU.0000194845.19462.7B","article-title":"Magnetic Resonance Imaging-Based Volumetric Analysis of Basal Ganglia Nuclei and Substantia Nigra in Patients with Parkinson's Disease","volume":"58","author":"DY Geng","year":"2006","journal-title":"Neurosurgery"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2047-9158-1-17","article-title":"Reduced striatal volumes in Parkinson's disease: a magnetic resonance imaging study","volume":"1","author":"TL Pitcher","year":"2012","journal-title":"Transl Neurodegener"},{"key":"ref14","first-page":"687e8","article-title":"Hippocampal, caudate, and ventricular changes in Parkinson\u2019s disease with and without dementia","volume":"25","author":"LG Apostolova","year":"2010","journal-title":"MovDisord"},{"key":"ref15","article-title":"Framework for the statistical shape analysis of brain structures using SPHARM-PDM","volume":"242","author":"M Styner","year":"2006","journal-title":"Insight J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mds.25904","article-title":"Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis","volume":"29","author":"N Carriere","year":"2014","journal-title":"Mov Disord"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.neurobiolaging.2013.05.017","article-title":"Striatal shape in Parkinson's disease","volume":"34","author":"NW Sterling","year":"2013","journal-title":"Neurobiol Aging"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.parkreldis.2014.03.009","article-title":"Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia","volume":"20","author":"HM Lee","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref19","first-page":"165","article-title":"Parkinson's Disease Society Brain Bank, London: overview and research","volume":"39","author":"SE Daniel","year":"1993","journal-title":"J Neural Transm Suppl"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"M Emre","year":"2007","journal-title":"Mov Disord"},{"key":"ref21","article-title":"text revision.","year":"2000"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2012.02.008","article-title":"Differential susceptibility to the PPAR-\u03b3 agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease","volume":"65","author":"C Laloux","year":"2012","journal-title":"Pharmacol Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","article-title":"The effect of age on the non-haemin iron in the human brain","volume":"3","author":"B Hallgren","year":"1958","journal-title":"J Neurochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3174\/ajnr.A0951","article-title":"Age-dependent normal values of T2* and T2' in brain parenchyma","volume":"29","author":"S Siemonsen","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.acra.2013.09.018","article-title":"Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages","volume":"21","author":"ME Rossi","year":"2014","journal-title":"Acad Radiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"D Kaur","year":"2003","journal-title":"Neuron"},{"key":"ref27","first-page":"234","article-title":"Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease","volume":"22","author":"LH You","year":"2015","journal-title":"Neuroscience"},{"key":"ref28","article-title":"Automated segmentation of basal ganglia and deep brain structures in MRI of Parkinson's disease","volume":"18","author":"C Haegelen","year":"2012","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.22592","article-title":"Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease","volume":"71","author":"DH Kwon","year":"2012","journal-title":"Ann Neurol"},{"key":"ref30","first-page":"309","article-title":"Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging","volume":"28","author":"L Minati","year":"2007","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0147947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:14:44Z","timestamp":1588983284000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0147947"}},"subtitle":[],"editor":[{"given":"Sheila M","family":"Fleming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0147947","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}